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PLMS and cardiovascular (CV) mortality 
and morbidity first in secondary RLS by 
us (5) and then verified in idiopathic RLS 
patients (6) as well.
PLMS and CardiovaSCuLar riSk
We recently reported that uremic RLS 
patients with severe PLMS experienced 
further detrimental alterations in cardiac 
structure in comparison to PLMS-free 
uremic RLS patients. These alterations 
included an increased left ventricular inter-
nal diameter in diastole, which lead to a 
significantly increased left ventricular mass 
compared to their PLMS-free counterparts 
(5). In addition, systolic blood pressure dur-
ing sleep correlated with left ventricular 
mass, indicating therefore an association 
of PLMS and raised nocturnal blood pres-
sure levels (non-dipping effect), with the 
later to be associated with left ventricular 
hypertrophy (LVH) (7). Still, an increase 
in nocturnal blood pressure levels induced 
by PLMS has been reported in idiopathic 
RLS patients (3) and very recently in healthy 
RLS-free individuals (8) as well. Of course 
in our study the compounding effect of 
renal disease per se could not be totally dis-
regarded. However, in a recent study, Mirza 
and colleagues reported that frequent PLMS 
was independently associated with severe 
LVH in idiopathic RLS patients, and thus 
concluded that PLMS could be considered 
as a risk factor for increased CV morbid-
ity and mortality (6). Interestingly, in the 
same study, PLMS was found to be stronger 
independent predictor of LVH, compared to 
introduCtion
Periodic limb movements in sleep (PLMS) 
is a common sleep disorder in both the 
general population and in patients with 
chronic diseases such as patients receiv-
ing hemodialysis therapy. PLMS can be 
assessed during an overnight polysomno-
graphic examination and are described as 
repetitive, stereotypical, and unconscious 
leg movements that occur during sleep. It 
is noteworthy, that PLMS are present in up 
to 80% of patients with a condition occur-
ring during wakefulness, called restless legs 
syndrome (RLS). Indeed, the presence of 
PLMS is considered to be one of the sup-
portive criteria for the diagnosis of the 
later condition (1). PLMS may also occur 
in patients with sleep apnea, narcolepsy, 
and rapid eye movement behavior disorder 
or even can be present in patients without 
any sleep or medical-related pathologi-
cal condition, and especially in the elderly 
(2). PLMS could cause significant sleep 
disturbance and result in non-restorative 
sleep via its associated arousals and motor 
restlessness. It is logical then to assume that 
as PLMS interferes with the expected sleep 
associated dipping of blood pressure (3), 
it may constitute a risk factor for cardiac 
disease and mortality. Notably, a role of 
PLMS as a predictor of mortality has been 
proposed in small survival study by Benz 
et al. (4) in which PLMS was strongly and 
independently associated with mortality in 
renal patients. Recently direct observations 
on cardiac structure added strong support 
on the association between the severity of 
apnea-hypopnea index. These new results 
come to further support our earlier obser-
vations on the association of PLMS with 
cardiac structure alterations in second-
ary RLS patients and more specifically in 
patients with uremic RLS.
Research findings highlighting an 
association between RLS disorder and 
an increased risk for CV disease has been 
slowly accumulating during the last years 
alerting the health care providers (especially 
the cardiologists) of the potential harmful 
impact of both idiopathic (9) and uremic 
(10) – forms of those conditions on CV 
morbidity and mortality. As mentioned 
earlier however PLMS coexists with RLS in 
∼80% of RLS cases. It is still unclear whether 
it is the severity of RLS or the severity of 
PLMS that may provoke the increased CV 
risk. According to our findings, the sever-
ity of RLS symptoms, as assessed by the 
gold standard method, the International 
RLS Study Group questionnaire, did not 
seem to affect cardiac structure indices (5). 
However, in our study, it was the severity 
of PLMS that was associated with LVH in 
uremic RLS patients. In addition, PLMS 
severity was associated with increased CV 
risk in uremic patients independently of the 
presence of obstructive sleep apnea (11). 
Taking into account our data in uremic 
patients (5) and the data of Mirza et al. (6) 
in idiopathic RLS patients it appears that 
the major contributor to cardiac structure 
abnormalities in RLS patients (either idi-
opathic or uremic) is the severity of PLMS 
and not the severity of RLS.
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focus on shedding light on this issue in 
both the idiopathic and secondary forms 
of the syndrome. It should be noted that as 
exercise is well known to induce significant 
improvements in CV health, it could con-
stitute a very promising RLS management 
approach, especially in those patients with 
high CV disease risk.
The usage of techniques such as echocar-
diography to assess the structural and func-
tional capacity of a patient’s heart should 
supported for both the screening for pos-
sible CV risk in the RLS/PLMS patients as 
well as the continuing monitoring of the 
longitudinal effects of provided treatments 
and disease progression on parameters 
related to the patient’s CV health.
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The later outcome should receive special 
consideration as it seems that the presence 
of PLMS is a potential CV risk factor with 
longitudinal negative outcome, indepen-
dently from the presence of other chronic 
pathological conditions and/or sleep dis-
orders [verifying early suggestions by Benz 
et al. (4)].
Cardiovascular disease is one of the lead-
ing causes of death in almost all societies 
while it is the main cause of mortality in 
the uremic population as well. The data 
derived by the only two published stud-
ies that used echocardiography so far to 
examine the association between PLMS 
and cardiac structure abnormalities (5, 6) 
reveal that this frequent sleep disorder could 
induce or worsen the severity of LVH and 
thus increase the risk for development of 
new or aggravation of existing CV disease. 
The fact that PLMS constitutes a common 
sleep disorder in both the general popula-
tion and in many chronic diseases such as 
renal disease should alert the medical and 
scientific community to the need for its suc-
cessful diagnosis and treatment in order to 
reduce its potential impact on CV health. 
However, we should note that data so far 
are derived from cross-sectional studies, 
and therefore the results should be seen with 
caution while, it is not easy to extend those 
conclusions into the general population.
PerSPeCtive and reSearCh 
direCtionS
According to the literature both idiopathic 
and secondary RLS/PLMS can be success-
fully managed mainly by using dopamine 
agonists, such as ropinirole, pramipexole, 
and rotigotine, which is considered to be 
the first line treatment option, while sub-
stances such as gabapentin have also been 
approved by international associations for 
the treatment of RLS/PLMS symptoms 
(12). In addition, non-pharmacological 
approaches such as exercise training appear 
to be effective in the amelioration of RLS/
PLMS symptoms in both idiopathic (13) 
and uremic (14, 15) patients. It is still 
unknown whether successful treatment of 
RLS/PLMS symptoms could induce favora-
ble changes on parameters related to CV 
health in parallel to the amelioration of the 
symptoms severity. Further research should 
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